sameAs
Transmission Dynamics of Zika Virus in Island Populations: A Modelling Analysis of the 2013–14 French Polynesia OutbreakModeling infectious disease dynamics in the complex landscape of global healthEpidemiology of varicella zoster virus infection in Canada and the United KingdomHuman papillomavirus and HPV vaccines: a reviewThe average cost of measles cases and adverse events following vaccination in industrialised countries.Developing a realistic sexual network model of chlamydia transmission in Britain.The Epidemiology of Rift Valley Fever in Mayotte: Insights and Perspectives from 11 Years of DataComparative Analysis of Dengue and Zika Outbreaks Reveals Differences by Setting and VirusEfficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)A review of typhoid fever transmission dynamic models and economic evaluations of vaccinationExposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpoxAedes aegypti Control Through Modernized, Integrated Vector ManagementNosocomial transmission of C. difficile in English hospitals from patients with symptomatic infectionSocial contacts and mixing patterns relevant to the spread of infectious diseasesDisease severity determines health-seeking behaviour amongst individuals with influenza-like illness in an internet-based cohort.The 2013–2016 Ebola epidemic: multidisciplinary success conceals a missed opportunityThe impact of control strategies and behavioural changes on the elimination of Ebola from Lofa County, LiberiaEvaluating the frequency of asymptomatic Ebola virus infectionDelaying the international spread of pandemic influenza.Analyses of the 1957 (Asian) influenza pandemic in the United Kingdom and the impact of school closures.Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study.Partially wrong? Partial equilibrium and the economic analysis of public health emergencies of international concern.Precautionary behavior in response to perceived threat of pandemic influenza.Cost-effectiveness of antiviral stockpiling and near-patient testing for potential influenza pandemic.Dynamic social networks and the implications for the spread of infectious disease.Seven challenges for model-driven data collection in experimental and observational studies.Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North America.The possible macroeconomic impact on the UK of an influenza pandemic.Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.The impact of illness and the impact of school closure on social contact patterns.Internet-based surveillance of Influenza-like-illness in the UK during the 2009 H1N1 influenza pandemic.The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based studyDifferent transmission patterns in the early stages of the influenza A(H1N1)v pandemic: a comparative analysis of 12 European countries.Rapid assessment of influenza vaccine effectiveness: analysis of an internet-based cohort.Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic modelsEstimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on reception into prison.Using time-use data to parameterize models for the spread of close-contact infectious diseases.Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom.Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease.Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales.
P50
Q24261176-012ABA29-5C6C-451D-B652-785600381625Q24277713-2604623F-0431-40B2-91DD-D3C9B0964E21Q24618133-A01ED8FE-0B6B-4054-AFFB-A59CA34E5EE8Q24657891-67E87DAB-C9B7-4F78-AD5F-5BFA6134DFFEQ24804057-38D2400B-D09A-4862-B180-9A866C9FD593Q25257521-E6DF8ED2-32B5-4539-90D7-24D1B5B5D81BQ26315278-9A5F5F4B-5619-4C03-9E8A-F51A775B2DDBQ27980447-1E4C1845-BDF2-4B83-B25A-C1BCD434D53DQ28051937-490A63D6-F675-4EA4-8048-5D31785A784FQ28088491-B714D468-27F5-41DB-ADDC-BECFB756497BQ28111950-31E7184A-D120-4A99-AFE2-FD86F8AA05A5Q28111950-704ED3C6-AF64-49F8-812D-A854D0F18FC6Q28580595-B7E0CE93-BA8E-41C5-8C3E-70300FCA9E11Q28658118-E7EA76B5-24A0-477D-B84A-929849BEE83DQ28755323-A63947D1-230E-45A6-8BE1-1DD81439F4C4Q30148785-5AC3673C-9705-403D-86F9-121947109665Q30251094-5987F3BB-0BB4-497D-899C-0FEDD2B036BFQ30251094-F72FFAB7-1491-4505-B9A0-FC1D3E4FB052Q30251097-39916B4E-4B54-4F41-A475-D57865B0C105Q30251097-D8064271-7FE3-4479-BD5D-4FEC16EB336EQ30251098-F6E9B9DB-FA8D-42AA-9346-A7EEA79683B0Q30354068-0F95297D-F486-4B3B-B80D-6E37C0E06D1EQ30361180-A7EA38F5-CC52-40B5-B953-5517149E0870Q30361230-21D340B1-F660-4315-B1C8-EBC8B13048D3Q30367565-CA64BDA2-EE06-40E1-8BD8-6DFA0ACAD018Q30367594-4C338BA6-170D-426B-8399-C672FB189EFCQ30367643-9A78B8BA-B7EB-430C-9BF2-832F2C0798EFQ30368071-010274E0-0A21-4438-AC01-D237568464FAQ30373408-659BD7E2-8DAB-466A-BCE1-E0547A3BA5C7Q30380066-5221467E-FA78-434C-9FE6-2D324986698EQ30381511-A9F4D686-2BDE-47A6-8F94-5DBE642F0907Q30384775-B0D42FE0-777A-49CB-8118-78211E268705Q30391394-39BD2495-8446-4A4B-AA60-1480A28A4E78Q30395325-883D4471-AAA9-4D2D-BF28-B3031BDB75EBQ30400700-A496BB1D-00C0-4F4A-A9C4-9BAC119460FBQ30403272-0F78F5F9-4828-48F8-BF19-181D3D1F3CAFQ30406933-D0441B4E-33A0-4397-BFF5-3236134969D1Q31086859-87C5B40A-82C0-4B93-8771-950D8C3020B1Q33248072-AA7120AB-05A7-420B-ACAE-06664B230EBAQ33370506-9E1DF9B2-E760-4C4F-8D39-A68CBE88DF4D
P50
description
British epidemiologist
@en
name
W. John Edmunds
@en
W. John Edmunds
@sl
type
label
W. John Edmunds
@en
W. John Edmunds
@sl
altLabel
John Edmunds
@en
William John Edmunds
@en
prefLabel
W. John Edmunds
@en
W. John Edmunds
@sl
P2671
P106
P1960
4UihVasAAAAJ
P21
P213
0000 0001 3438 3861
P2671
/g/11ftz46nld
P31
P4012
P463
P496
0000-0002-9179-2917